Investigation of the Epidemiological Factors Associated With the Development of Amyotrophic Lateral Sclerosis (ALS)
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- ALS
- Sponsor
- Hadassah Medical Organization
- Enrollment
- 2000
- Locations
- 1
- Primary Endpoint
- Progression rate
- Status
- Recruiting
- Last Updated
- 5 years ago
Overview
Brief Summary
Investigation of the epidemiological factors associated with amyotrophic lateral sclerosis (ALS) in Israel with a view to future international collaboration. Particularly addressing:-
- Differences between ethnic subgroups
- Differences between immigrant and native-born populations
- Differences according to military service profile Clinical features gathered at each routine visit ,throughout the entire course of the disease, will be recorded in database format, in order to correlate with potential epidemiological factors.
Detailed Description
Investigation of the epidemiological factors associated with amyotrophic lateral sclerosis (ALS) in Israel with a view to future international collaboration. Particularly addressing:- 1. Differences between ethnic subgroups 2. Differences between immigrant and native-born populations 3. Differences according to military service profile Clinical features gathered at each routine visit ,throughout the entire course of the disease, will be recorded in database format, in order to correlate with potential epidemiological factors. The clinical features will include pattern of onset, details of full clinical exam ( including ALSFRS-R score, power, reflexes, and other signs of upper or lower-motor neuron dysfunction. Correlations between different clinical parameters themselves will be made, as well as correlation between clinical parameters and other epidemiological factors.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Suspected, possible, probable ,definite ALS
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Progression rate
Time Frame: up to 10 years
Progression of ALSFRS-R score over time
Secondary Outcomes
- Appearance of clinical features of UMN or LMN dysfunction(10 years)